titanium has been researched along with diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv) in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frühauf, S; Zeller, WJ | 1 |
Berger, MR; Heim, ME; Keppler, BK | 1 |
Keppler, BK; Schmähl, D | 1 |
Berger, MR; Bischoff, H; Keppler, BK; Schmähl, D | 1 |
Keppler, B; Mattern, J; Volm, M | 1 |
Buschmann, R; Dubler, E; Schmalle, HW | 1 |
Caruso, F; Rossi, M | 1 |
Alexander, JS; Manna, CM; Peri, D; Shavit, M; Tshuva, EY | 1 |
Garcia e Costa, F; Pereira, ML | 1 |
2 review(s) available for titanium and diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv)
Article | Year |
---|---|
New tumor-inhibiting metal complexes.
Topics: Animals; Antineoplastic Agents; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Rats; Ruthenium; Structure-Activity Relationship; Titanium | 1990 |
Antitumor titanium compounds.
Topics: Antineoplastic Agents; DNA Adducts; Drug Design; Molecular Structure; Organometallic Compounds; Protein Binding; Telomerase; Titanium; Topoisomerase II Inhibitors | 2004 |
7 other study(ies) available for titanium and diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv)
Article | Year |
---|---|
New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
Topics: Animals; Crown Ethers; DNA, Neoplasm; Drug Screening Assays, Antitumor; Ethers, Cyclic; Ethylnitrosourea; Female; Indazoles; Organometallic Compounds; Organophosphorus Compounds; Organoplatinum Compounds; Ovarian Neoplasms; Rats; Ruthenium; Titanium | 1991 |
Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Cisplatin; Columbidae; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Organometallic Compounds; Rats; Sarcoma 180; Titanium | 1986 |
Efficacy of beta-diketonato complexes of titanium, zirconium, and hafnium against chemically induced autochthonous colonic tumors in rats.
Topics: Animals; Body Weight; Carcinogens; Colonic Neoplasms; Dimethylnitrosamine; Hafnium; Male; Metals; Organometallic Compounds; Rats; Rats, Inbred Strains; Titanium; Zirconium | 1987 |
Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
Topics: Animals; Antineoplastic Agents; Body Weight; Cisplatin; Cyclophosphamide; Drug Evaluation; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Organometallic Compounds; Titanium; Transplantation, Heterologous | 1984 |
Isomer abundance of bis(beta-diketonato) complexes of titanium(IV). Crystal structures of the antitumor compound budotitane [Ti(IV)(bzac)(2)(OEt)(2)] and of its dichloro-derivative [Ti(IV)(bzac)(2)Cl(2)] (bzac=1-phenylbutane-1,3-dionate).
Topics: Antineoplastic Agents; Crystallography, X-Ray; Hydrocarbons, Chlorinated; Isomerism; Models, Molecular; Organometallic Compounds; Structure-Activity Relationship; Temperature; Thermogravimetry; Titanium | 2003 |
Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands.
Topics: Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Diamines; Drug Screening Assays, Antitumor; Female; HT29 Cells; Humans; Ligands; Organometallic Compounds; Ovarian Neoplasms; Phenols; Titanium | 2007 |
The blood-testis barrier as a target of some chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Blood-Testis Barrier; Horseradish Peroxidase; Male; Mice; Mice, Inbred ICR; Organometallic Compounds; Testis; Titanium | 2007 |